Skip to Main Content

Author Details

Jeffrey A Toretsky
Georgetown University Medical Center, Georgetown University
1986
125
47
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37732905Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.Cancer Res Commun2023
37732905Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.Cancer Res Commun2023
35047826Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcoma.NAR Cancer2022
35486030Coupling Lipid Labeling and Click Chemistry Enables Isolation of Extracellular Vesicles for Noninvasive Detection of Oncogenic Gene Alterations.Adv Sci (Weinh)2022
36417526Widespread hypertranscription in aggressive human cancers.Sci Adv2022
36115869An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.NPJ Precis Oncol2022
35047826Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcoma.NAR Cancer2022
35486030Coupling Lipid Labeling and Click Chemistry Enables Isolation of Extracellular Vesicles for Noninvasive Detection of Oncogenic Gene Alterations.Adv Sci (Weinh)2022
36417526Widespread hypertranscription in aggressive human cancers.Sci Adv2022
36115869An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.NPJ Precis Oncol2022
34304571<i>O</i>-Linked-<i>N</i>-Acetylglucosaminylation of the RNA-Binding Protein EWS N-Terminal Low Complexity Region Reduces Phase Separation and Enhances Condensate Dynamics.J Am Chem Soc2021
37168767The Use of Hyperbaric Oxygen Therapy in the Management of Severe Radiation-Induced Hemorrhagic Gastritis in a Pediatric Patient.JPGN Rep2021
33751768Afebrile S. aureus bacteremia in two patients with hemophagocytic lymphohistiocytosis receiving emapalumab/dexamethasone/etoposide.Pediatr Blood Cancer2021
33941613Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response.Cancer Res2021
34304571<i>O</i>-Linked-<i>N</i>-Acetylglucosaminylation of the RNA-Binding Protein EWS N-Terminal Low Complexity Region Reduces Phase Separation and Enhances Condensate Dynamics.J Am Chem Soc2021
34133426Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells.PLoS One2021
33919988Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives.J Clin Med2021
37168767The Use of Hyperbaric Oxygen Therapy in the Management of Severe Radiation-Induced Hemorrhagic Gastritis in a Pediatric Patient.JPGN Rep2021
33919988Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives.J Clin Med2021
33751768Afebrile S. aureus bacteremia in two patients with hemophagocytic lymphohistiocytosis receiving emapalumab/dexamethasone/etoposide.Pediatr Blood Cancer2021
34133426Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells.PLoS One2021
33941613Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response.Cancer Res2021
32815894Rapid and Complete Response to Combination Anti-CTLA-4 and Anti-PD-1 Checkpoint Inhibitor Therapy in a Patient With Stage IV Refractory End-stage Epithelioid Sarcoma: A Case Report.J Immunother2020
32016454Development of an Ewing sarcoma cell line with resistance to EWSâ¿¿FLI1 inhibitor YKâ¿¿4â¿¿279.Mol Med Rep2020
34220409Coupling Nanostructured Microchips with Covalent Chemistry Enables Purification of Sarcoma-Derived Extracellular Vesicles for Downstream Functional Studies.Adv Funct Mater2020
32815894Rapid and Complete Response to Combination Anti-CTLA-4 and Anti-PD-1 Checkpoint Inhibitor Therapy in a Patient With Stage IV Refractory End-stage Epithelioid Sarcoma: A Case Report.J Immunother2020
32680570A novel PARD3B-NUTM1 fusion in an aggressive primary CNS embryonal tumor in a young adult.Acta Neuropathol Commun2020
34220409Coupling Nanostructured Microchips with Covalent Chemistry Enables Purification of Sarcoma-Derived Extracellular Vesicles for Downstream Functional Studies.Adv Funct Mater2020
32016454Development of an Ewing sarcoma cell line with resistance to EWSâ¿¿FLI1 inhibitor YKâ¿¿4â¿¿279.Mol Med Rep2020
32680570A novel PARD3B-NUTM1 fusion in an aggressive primary CNS embryonal tumor in a young adult.Acta Neuropathol Commun2020
31025088Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis.J Mol Med (Berl)2019
31182435The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents.Clin Cancer Res2019
31025088Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis.J Mol Med (Berl)2019
31392992EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.Nucleic Acids Res2019
31182435The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents.Clin Cancer Res2019
31392992EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.Nucleic Acids Res2019
29655986Targeting Intrinsically Disordered Transcription Factors: Changing the Paradigm.J Mol Biol2018
30123424Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.Oncotarget2018
30166462Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors.Science2018
29950716Author Correction: EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.Nature2018
29382926Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.Oncogene2018
29655986Targeting Intrinsically Disordered Transcription Factors: Changing the Paradigm.J Mol Biol2018
29513652EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.Nature2018
29778411A probable primary malignant bone tumor in a pre-Columbian human humerus from Cerro Brujo, Bocas del Toro, Panamá.Int J Paleopathol2018
30166462Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors.Science2018
30123424Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.Oncotarget2018
29950716Author Correction: EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.Nature2018
29778411A probable primary malignant bone tumor in a pre-Columbian human humerus from Cerro Brujo, Bocas del Toro, Panamá.Int J Paleopathol2018
29382926Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.Oncogene2018
29513652EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.Nature2018
  • 1 - 50 of 250

Recommended Authors

Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Instituto de Salud Carlos III
Career Start Year 2009
Number of shared co-authors 14
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 4
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 8
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 15
University of Virginia
Career Start Year 2000
Number of shared co-authors 2
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 17
Memorial Sloan-Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 19
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 14
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 16
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1993
Number of shared co-authors 10
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 18
Children's Cancer Research Institute
Career Start Year 1991
Number of shared co-authors 7
University Medical Center Freiburg, University of Freiburg
Career Start Year 1990
Number of shared co-authors 17
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 7
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 4
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 4
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 10
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 1987
Number of shared co-authors 7
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 8
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1983
Number of shared co-authors 21
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 3
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 2
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 13
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 13
Center for Epigenetics, Van Andel Research Institute
Career Start Year 1971
Number of shared co-authors 34

Collaborators

Georgetown University Medical Center
Co-authored papers 45
Co-authored papers 16
Co-authored papers 13
Osteosarcoma Institute
Co-authored papers 11
St. Anna Children's Cancer Research Institute (CCRI), Medical University Vienna
Co-authored papers 10
Co-authored papers 9
Seattle Children's Research Institute
Co-authored papers 7
Illumina Inc.
Co-authored papers 6
Dana-Farber Cancer Institute
Co-authored papers 6
The Ohio State University College of Medicine
Co-authored papers 5
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
University Hospital Essen, West German Cancer Center
Co-authored papers 5
Georgetown University
Co-authored papers 5
The University of Texas Health Science Center at San Antonio
Co-authored papers 4
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Co-authored papers 4
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Co-authored papers 4
Keck School of Medicine of the University of Southern California
Co-authored papers 4
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
Co-authored papers 4
Cancer Center of Lyon
Co-authored papers 4
University Hospital Erlangen
Co-authored papers 4
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 3
Co-authored papers 3
German Cancer Research Center
Co-authored papers 3
University Children's Hospital Muenster
Co-authored papers 3
Co-authored papers 3
St. Anna Children's Cancer Research Institute (CCRI), Medical University of Vienna
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3